For more than two decades, researchers at the University of Basel, Switzerland, have been investigating a severe form of muscular dystrophy in which muscles progressively degenerate. The research team ...

Sept 12 (Reuters) - Fulcrum Therapeutics (FULC.O), opens new tab said on Thursday its experimental drug to treat a type of muscle disorder failed to meet the main goal in a late-stage study, sending ...

A single 5-mg infusion of zoledronic acid administered before bariatric surgery did not prevent loss of muscle mass or strength nor did it improve physical function 12 months after surgery compared ...

(Reuters) - GTx Inc said its experimental drug to treat muscle wasting in cancer patients was not effective in improving body mass in late-stage trials. A 3-mg dose of the drug, enobosarm, was tested ...